Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The Moderna vaccine vial lot 015B22A which was expired on 12-Feb-2023, was initially stored in refrigerator on 23-Feb-2023 and administered on 23-Feb-2023; No Adverse Event; 5 patients were given expired doses. Four patients did not report adverse reaction; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (5 patients were given expired doses. Four patients did not report adverse reaction), PRODUCT STORAGE ERROR (The Moderna vaccine vial lot 015B22A which was expired on 12-Feb-2023, was initially stored in refrigerator on 23-Feb-2023 and administered on 23-Feb-2023) and NO ADVERSE EVENT (No Adverse Event) in an elderly patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 015B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Feb-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 23-Feb-2023,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (5 patients were given expired doses. Four patients did not report adverse reaction). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The Moderna vaccine vial lot 015B22A which was expired on 12-Feb-2023, was initially stored in refrigerator on 23-Feb-2023 and administered on 23-Feb-2023) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (5 patients were given expired doses. Four patients did not report adverse reaction), PRODUCT STORAGE ERROR (The Moderna vaccine vial lot 015B22A which was expired on 12-Feb-2023, was initially stored in refrigerator on 23-Feb-2023 and administered on 23-Feb-2023) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (5 patients were given expired doses. Four patients did not report adverse reaction) and PRODUCT STORAGE ERROR (The Moderna vaccine vial lot 015B22A which was expired on 12-Feb-2023, was initially stored in refrigerator on 23-Feb-2023 and administered on 23-Feb-2023).    No concomitant medication information was provided. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine The email received enquiring about the Moderna vaccine lot 015B22A which was expired on 12-Feb-2023 administered on 23-Feb-2023 if these doses need to be repeated. reporter states that 5 patients were given expired doses. Four patients did not report adverse reaction. The vial was initially stored in refrigerator on 23-Feb-2023 and administered on 23-Feb-2023  The vial size was unsure if 2.5 ml. It was reported that the vial did not undergo temperature excursions. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-715162 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715162:Same reporter (4 patient's case)